Hospital
Little River Medical Center, INC.
Little River Medical Center, INC. was paid $562K by Medicaid between Jan 2018 and Nov 2024, across 49 billing codes. Its largest line is 87502, Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets — 17% of everything it billed.
33Billing provider infoLITTLE RIVER MEDICAL CENTER, INC.
ASHDOWN, AR 71822
ASHDOWN, AR 71822
33aNPI1326040007assigned 08/12/2005
33bProvider typeCritical Access Hospital
28Total paid$562K
24GClaims32,846
24DCodes billed49
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Arkansas
Rank by total paid#21 of 34
Median peer was paid$773K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,417 | $59K | |
| 2019 | 5,410 | $78K | |
| 2020 | 4,547 | $67K | |
| 2021 | 4,886 | $86K | |
| 2022 | 5,140 | $124K | |
| 2023 | 3,999 | $94K | |
| 2024incomplete | 2,447 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 17% | 1,035 | 939 | $97K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 17% | 2,290 | 455 | $95K |
| 80053 | Comprehensive metabolic panel | 11% | 4,591 | 3,870 | $60K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.4% | 5,784 | 4,613 | $53K |
| 80050 | General health panel | 5.7% | 763 | 686 | $32K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.0% | 691 | 626 | $28K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.5% | 682 | 620 | $25K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.5% | 509 | 426 | $20K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.5% | 398 | 324 | $20K |
| 80061 | Lipid panel | 3.4% | 2,088 | 1,879 | $19K |
| 71046 | Radiologic examination, chest; 2 views | 2.4% | 758 | 661 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.9% | 1,704 | 1,541 | $11K |
37 more codes
| 81000 | 1.6% | 2,891 | $9K | |
| 99285 | Emergency room visit (most serious) | 1.4% | 178 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.3% | 1,212 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 778 | $7K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 1,087 | $7K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.0% | 45 | $6K |
| 87634 | <1% | 105 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 868 | $5K |
| 83880 | <1% | 117 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 706 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 240 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 94 | $3K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 60 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 167 | $2K |
| 84439 | <1% | 236 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 638 | $1K |
| 82550 | <1% | 241 | $1K | |
| 82552 | <1% | 132 | $1K | |
| 71020 | <1% | 56 | $963.71 | |
| 84484 | <1% | 184 | $924.62 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 16 | $842.16 |
| 80305 | <1% | 65 | $833.40 | |
| 87077 | <1% | 132 | $769.65 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 126 | $769.60 |
| 0001A | <1% | 14 | $700.00 | |
| 83735 | <1% | 94 | $623.65 | |
| 85610 | <1% | 256 | $586.96 | |
| 97161 | <1% | 16 | $510.62 | |
| 82607 | <1% | 25 | $479.25 | |
| 81025 | <1% | 56 | $461.56 | |
| 71045 | Radiologic examination, chest; single view | <1% | 66 | $347.14 |
| 86308 | <1% | 31 | $314.66 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 440 | $259.80 |
| 83690 | <1% | 14 | $98.40 | |
| 82150 | <1% | 17 | $83.34 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 126 | $74.60 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 24 | $21.70 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKEENER, VICKI (ADM. ASSISTANT)
Parent organizationLITTLE RIVER MEDICAL CENTER, INC.
| Provider | Location | Paid |
|---|---|---|
| Little River Medical Center, INC. | Ashdown, AR | $462K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.